Your session is about to expire
← Back to Search
Oxaloacetate for Cognitive Function in Breast Cancer Survivors
Study Summary
This trial looks at whether oxaloacetate, a natural substance found in the body, can help reduce cognitive complaints in breast cancer survivors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any serious illnesses or social situations that would stop me from following the study's requirements.I was diagnosed with early stage breast cancer, finished initial treatments over a year ago, but it's been less than 5 years since my diagnosis.I have a serious health or mental condition that could affect my participation in the study.You have had allergic reactions to substances similar to oxaloacetate.I don't have active breast cancer or any serious chronic illness.I agree to use birth control during the study if I can become pregnant.I am not pregnant or breastfeeding.I am not on medications that affect my thinking, like those for sleep or pain.You have reported significant problems with your memory and thinking skills, as measured by a specific test.
- Group 1: Supportive care (anhydrous enol-oxaloacetate)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people are a part of this clinical study?
"From what is published on clinicaltrials.gov, it seems that this trial is still recruiting patients. The listing shows that the trial was first posted on September 29th 2021 and was last edited March 17th 2022. They are looking for a total of 24 participants at a single site."
To whom is this research available?
"This study is looking for 24 participants who are currently breast cancer patients and fall within the ages of 18-74. Additionally, it is important that patients meet the following criteria: Women with a diagnosis of early stage breast cancer (stage 0, I, II, IIIa) who are at least 12 months after surgery, chemotherapy, radiation, but may be on endocrine therapy or HER-2 targeted therapy, and not more than 5 years after their breast cancer diagnosis; No evidence of active/recurrent breast cancer or other serious chronic illness; Has significant cognitive complaints, defined as a score of < 12 on the Patient-Rep"
What are some of the dangers that Anhydrous Enol-oxaloacetate poses to patients?
"This clinical trial is still in its early stages, so not much is known about the safety of Anhydrous Enol-oxaloacetate. However, data collected so far suggests that it is safe to use, and it received a score of 2."
Does this research project allow patients that are above the age of 60 to enroll?
"This particular study is only enrolling patients aged 18-74. However, there are 65 trials specifically designed for children and 2290 clinical trials that cater to adults over the age of 65."
Are there any available spots left for participants in this experiment?
"Yes, this study is still recruiting participants. The listing on clinicaltrials.gov shows that the trial was posted on 9/29/2021 and updated as recently as 3/17/2022."
Share this study with friends
Copy Link
Messenger